← All trials
NCT03490123
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2018
- Primary completion
- Apr 30, 2019
- Completion date
- Apr 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 56000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Lihir Medical CentreLead sponsor
- Harvard UniversityCollaborator
- Government of Papua New GuineaCollaborator
- World Health OrganizationCollaborator
- Lihir Medical CentreReponsible party - principal investigator
- University of BarcelonaCollaborator
- University of MasarykovaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.